Affiliation:
1. Profil; Neuss Germany
2. Sanofi-Aventis Deutschland GmbH; Frankfurt Am Main Germany
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference8 articles.
1. Opportunities and challenges for biosimilars: what's on the horizon in the global insulin market?;Rotenstein;Clin Diabetes,2012
2. European Medicines Agency Guideline on non-clinical and clinical development of similar biological medicinal products containing recombinant human insulin and insulin analogues 2015 http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2015/03/WC500184161.pdf
3. An overview of current regulatory requirements for approval of biosimilar insulins;Heinemann;Diabetes Technol Ther,2015
4. Insulin glulisine, a new rapid-acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjects;Becker;Exp Clin Endocrinol Diabetes,2005
5. Recommendations guiding physicians in biomedical research involving human subjects;World Medical Association Declaration of Helsinki;JAMA,1997
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献